New Dawn pharma is considering the acquisition of a small biotech company$$Sunset Pharmaceuticals. Sunset is developing a new drug that, if successful, would revolutionize the treatment of pancreatic and$/$or liver cancer. Sunset is about to start Phase I of the clinical testing for the new drug. New Dawn estimates that if they acquired Sunset the costs associated with Phase I testing would be around $$60$ million. They believe the probability of successful Phase I testing is $30\%.$

Phase $2$ testing for the pancreatic cancer and$/$or liver cancer indication would cost $$170$ million. The probability that Phase $2$ testing will show effectiveness for pancreatic cancer is $25\%.$ The probability that Phase II will show clinical efficacy for liver cancer only is $45\%.$

Phase $3$ testing for the pancreatic cancer indication will cost $$300$ million. The probability that Phase $3$ testing for pancreatic cancer will be successful is $40\%,$ and the cost of launching the drug for the pancreatic indication only will be $$250$ million. New Dawn estimates that future cash flows from a successful pancreatic cancer indication will be in the vicinity of $$10$ billion.

Phase $3$ testing for the liver cancer indication only will cost $$350$ million. The probability that Phase $3$ testing will show effectiveness for liver cancer is $70\%,$ and the cost of launching the drug for the liver indication only will be $$200$ million. Estimates for future cash flows from a successful liver cancer launch are in the vicinity of $$20$ billion.

$($All cash flows are expressed in after$-$tax present values discounted to time zero, including capital expenditure.$)$

New Dawn estimates that the value created from the acquisition will be on the order of $$600$ million. They also think that the deal will need about $$0\mathrm{.}8$ million in Work. How much should New Deal be willing to pay in Consideration?